Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.004 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |